Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Learn how value tilts steer retirement portfolio index funds toward undervalued opportunities, balancing risk while pursuing higher long-term gains.
25,656 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
As a looming recession tests crypto narratives, Bitcoin’s fixed supply and growing institutional interest face off ag...
Planet Fitness posted a robust surge in revenue, but a large investor trimmed a substantial stake. This article break...
Prediction markets offer a different lens on big corporate moves. Discover what kalshi traders chance spacex says abo...
Amazon briefly overtook SpaceX as the world's fifth-largest company by market cap. Here are three reasons that leader...
IBM recently released a preliminary quarter that underscored a broader pattern: AI budgets are shifting. This article...
When a major momentum bet is unwound, it sends signals about risk tolerance and market breadth. This article explains...
Investors are shifting capital away from Tesla toward SpaceX and AI-driven platforms, reshaping how the market values...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
Public weddings draw headlines, but families still juggle budgets and calendars. This story explores jaime king’s exp...
As tuition climbs, 529 plans continue to be a powerful tool for families saving for college and vocational training. ...
Dogecoin remains near key support as the Musk-and-SpaceX narrative cools. Investors await fresh catalysts that could ...